Biocon Ltd Sees Heavy Put Option Activity Amid Bearish Market Sentiment

On 20 November 2025, Biocon's stock price stood at ₹393.4, having experienced a decline of 3.77% during the trading session. This performance underperformed the Pharmaceuticals & Biotechnology sector, which saw a marginal fall of 0.23%, while the Sensex recorded a slight gain of 0.17%. The stock has been on a downward trajectory for two consecutive days, accumulating a return loss of 6.55% over this period. Intraday lows touched ₹392.9, indicating selling pressure near the lower end of recent trading ranges.

Trading volumes have shown a shift in investor participation. Delivery volume on 19 November was recorded at 14.25 lakh shares, marking a decline of 59.76% compared to the five-day average delivery volume. This reduction in delivery volume suggests a lower commitment to holding shares, potentially reflecting hedging or protective strategies by market participants.

Biocon's weighted average traded price during the day was closer to the intraday low, reinforcing the bearish undertone. The stock's price remains above its 20-day, 50-day, 100-day, and 200-day moving averages, yet it trades below the 5-day moving average, indicating short-term weakness despite longer-term support levels.

The options market reveals further insights into investor sentiment. Biocon's put options with expiry on 25 November 2025 have attracted notable activity, particularly at strike prices ₹390 and ₹400. The ₹390 strike put option recorded 3,470 contracts traded, with a turnover of ₹312.3 lakh and an open interest of 1,218 contracts. Meanwhile, the ₹400 strike put option saw 2,999 contracts traded, generating a turnover of ₹507.58 lakh and an open interest of 823 contracts.

This concentration of put option volume near the current stock price suggests that investors are positioning for potential downside or are seeking to hedge existing long positions. The open interest figures indicate that these positions are not merely speculative but have some persistence, as traders maintain exposure through to expiry.

Liquidity in Biocon remains adequate for sizeable trades, with the stock's traded value representing approximately 2% of its five-day average, equating to a trade size capacity of ₹5.29 crore. This level of liquidity supports active options trading and allows market participants to execute hedging or speculative strategies with relative ease.

From a market capitalisation perspective, Biocon is classified as a mid-cap stock with a valuation of ₹54,795 crore. Its sector, Pharmaceuticals & Biotechnology, continues to face a complex environment with regulatory scrutiny, patent expiries, and competitive pressures impacting investor confidence. These factors may be contributing to the cautious positioning observed in the options market.

Analysing the strike prices of the most active put options, the ₹390 and ₹400 levels are closely aligned with the stock’s current trading range. This proximity indicates that investors are particularly focused on downside protection around these price points. The relatively high open interest at these strikes suggests that traders expect the stock to test or breach these levels before the expiry date.

Such put option activity can be interpreted as a form of insurance against further declines or as a speculative bet on weakening fundamentals or market conditions. Given the recent price weakness and reduced delivery volumes, the options data corroborates a market environment where caution prevails.

Investors should also note the broader market context. While Biocon’s sector has shown resilience in some periods, the stock’s recent underperformance relative to the sector and benchmark indices highlights the challenges it faces. The interplay between technical indicators, such as moving averages, and options market positioning provides a nuanced picture of investor expectations.

In summary, Biocon Ltd’s current market activity, particularly the surge in put option contracts near the ₹390-₹400 strike prices, reflects a defensive stance among traders. The stock’s recent price behaviour, combined with declining delivery volumes and active options trading, suggests that market participants are preparing for potential volatility or downside risk in the near term. Investors and traders should monitor these developments closely, considering both technical signals and options market trends to inform their strategies.

Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →